Dr. Xiaodong Cheng (M.D., Ph.D.) is currently a full Professor of Immunology, Oncology, and Integrative Medicine; Director of Institute of Clinical Immunology, Yue-Yang Hospital of Integrative Medicine, Shanghai University of Traditional Chinese Medicine (TCM). He is the"Oriental Outstanding Scholar" Honorable Professor and the "Pu-jiangOutstanding Talent" Distinguished Professor in China. He is a Guest Professor and Supervisor of PhD students in The Atlantic Institute of Oriental Medicine, USA. He is also a Guest Professor and one of theexpert members of the Jury Committee for Graduate Students' Thesis Defense in University of Joseph Fourier, France. He is not only a basicresearch scientist but also a clinical physician of TCM as well. 

Dr. Cheng got his M.D. and Ph.D. degree at Fudan University in 1996, and had his postdoctoral training at Shanghai Institute of Cell Biology, Chinese Academy of Sciences. Since 2000, he was awarded the Max-Planck Society Scholarship and was working as a visiting scientistat Max-Planck Institute of Neurobiology, Germany. After that, he moved to the USA to pursue his research in Thomas Jefferson University, Rutgers Pennsylvania; Blood Research Institute, Wisconsin; and University, New Jersey; respectively until 2009. He had beencontinuously working in Germany and the USA for about ten years in the fields of immuunology and integrative medicine. From 2009 to 2015, Dr. Cheng was appointed as a Chair Professor and Director of National TCM Great Master Training Program; Director of Department of Cellular and Molecular Immumology, School of Life Sciences and Technology; Director of Research Center of Pharmacology & Toxicology for TCM, Li-shui Institute of Traditional Chinese Medicine; Tongji University.

Right now, Dr. Cheng is an active member of the American Associationof Immunologists (AAD), USA; active member of The European GP-TCM Association (GP-TCM); the secretary-general of Shanghai region of The Consortium for Globalization of Chinese Medicine (CGCM); and active member of World Federal of Chinese Medicine Society (WFCMS).

Dr. Cheng's research interests are now focused on:

1. Immunopathogenesis of CNS autoimmne inflammatory diseases;

2. Regulation on tumor immune evasion with the immne costimlatorymolecular signaling;

3. Clinical trial and basic study on therapeutic approaches with naturalmedicine in treating autoimmune, infectious, and cancer diseases.